總的來說,這項研究表明調節(jié)性T細胞乳酸轉運蛋白MCT1的特異性缺失不僅導致腫瘤生長的減少,而且與檢查點阻斷免疫療法也有協(xié)同作用。抑制MCT1,直接靶向乳酸代謝可打破這種腫瘤與調節(jié)性T細胞的代謝共生關系,降低調節(jié)性T細胞對癌癥免疫的屏障。參考資料:1# Watson, M.J., Vignali, P.D.A., Mullett, S.J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature (2021)2# Cancer Tricks Immune Cells, Immunotherapy Can Take Advantage(來源:匹茲堡大學官網)